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Quantitative  NMR  spectroscopy  (qNMR)  is gaining  interest  across  both  analytical  and  industrial  research
applications  and  has  become  an  essential  tool  for the  content  assignment  and  quantitative  determination
of  impurities.
The key  beneﬁts  of  using  qNMR  as  measurement  method  for  the  purity determination  of  organic
molecules  are  discussed,  with  emphasis  on the  ability  to  establish  traceability  to “The  International
System  of Units”  (SI).  The  work  describes  a  routine  certiﬁcation  procedure  from the  point  of  view ofNMR
raceability
ccreditation
RM
tability testing
a  commercial  producer  of  certiﬁed  reference  materials  (CRM)  under  ISO/IEC  17025  and  ISO Guide  34
accreditation,  that  resulted  in  a set of essential  references  for 1H  qNMR  measurements,  and  the relevant
application  data  for these  substances  are  given.  The  overall process  includes  speciﬁc  selection  criteria,
pre-tests,  experimental  conditions,  homogeneity  and  stability  studies.  The  advantages  of an  accelerated
stability  study  over  the  classical  stability-test  design  are  shown  with  respect  to  shelf-life  determination
and  shipping  conditions.
© 2013  The  Authors.  Published  by  Elsevier  B.V. Open access under CC BY-NC-SA license.. Introduction
Nuclear magnetic resonance (NMR) spectroscopy was  ﬁrst
escribed in 1946 [1,2] and since then has become an essential
nalytical technique for chemical structure elucidation as well as
or purity and impurity determination. Today it is used in a variety
f different applications in industry as well as academic research.
ver the last two decades the importance of quantiﬁcation using
MR, especially by 1H NMR, has signiﬁcantly increased [3–6]. In
998 and 2005, Holzgrabe et al. published reviews which cov-
red different applications of NMR  spectroscopy in pharmacy [7],
n particular the application of quantitative NMR  [8]. Furthermore
everal international pharmacopeias describe qNMR methods for
he determination of the impurity proﬁle of drugs.
Jancke et al. proposed NMR  spectroscopy as a relative primary
nalytical method [9], because it can be described completely by
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Open access under CC BY-NC-SA lmathematical equations from which a full uncertainty budget may
be derived, allowing it to be employed at the highest metrological
level. He also made clear that 1H NMR  spectroscopy is appropri-
ate for quantitative analysis because of the high sensitivity of the
proton nuclei combined with relative short relaxation times and
virtually 100% natural abundance. The intensity of the NMR sig-
nal is directly proportional to the number of protons that give
rise to the signal. So quantiﬁcation is achieved by measuring the
sample peak area of interest with respect to a signal from an
appropriate internal standard, such as an internationally accepted
primary CRM. Using such a primary CRM, for example a Standard
Reference MaterialTM (SRM) from the US National Institute of Stan-
dards and Technology (NIST), leads to traceability to the SI without
the need for a reference standard of the same chemical structure
as the sample. For many organic samples a direct traceability to
a small set of internationally accepted reference standards can
be achieved [10–12]. Hence, qNMR is an ideal technique for the
certiﬁcation of small organic molecules as it achieves accurate
and traceable values in combination with very low uncertain-
ties.
Different referencing techniques have been tested for qNMR,
internal as well and external. Bharti and Roy gave a broad
overview over various methods including pros and cons [13].
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xternal referencing approaches comprise NMR-tubes with coaxial
nserts leading to a separation of analyte and standard. Fur-
hermore, electronic reference methods have been elaborated,
.g. ERETIC (Electronic REference To access In vivo Concentra-
ion), using an electronically generated signal as the internal
eference signal. Since the achievement of low measurement
ncertainties is a key issue for the development of CRM, sev-
ral authors described the use of the internal reference method
11,12,14].
In 2005, Malz and Jancke presented an approach for the vali-
ation of quantitative NMR. They developed a protocol for the
pplication of qNMR experiments that has been further tested
n a round robin test. Following this protocol they obtained an
xpanded measurement uncertainty of 1.5% with a coverage fac-
or of k = 2 [15]. In 2009 Ihara et al. from the National Metrology
nstitute of Japan (AIST) published their results for the certiﬁcation
f pesticides by 1H qNMR and their optimized 1H qNMR methods
ead to expanded measurement uncertainty values between 0.3%
nd 1.2% [14]. Weber et al. discussed in detail important aspects
f the procedure that allow the realization of low uncertainties in
NMR measurements [12]. Since the certiﬁcation of CRM requires
xpanded measurement uncertainties of less than 0.5% the work of
eber et al. demonstrated for the ﬁrst time that qNMR is able to
ulﬁll this criterion. The combination of sound metrological weigh-
ng with qNMR was therefore trademarked as high-performance
NMR (HP-qNMR®).
. Materials and methods
.1. Material
The primary CRM used were potassium hydrogen phtha-
ate (NIST SRM 84l, acidimetric standard: 99.9934% ± 0.0076%)
nd Benzoic acid (NIST SRM 350b, acidimetric standard:
9.9978% ± 0.0044%). Other candidate materials for use as internal
tandard CRM were purchased from Sigma–Aldrich and included:
alcium formate (Fluka no.: 03826), benzoic acid (Fluka no.: 06185),
uroquinone (Fluka no.: 06856), dimethyl terephthalate (Fluka
o.: 07038), potassium phthalate monobasic (Fluka no.: 14659),
,5-dinitrobenzoic acid (Fluka no.: 15639), 1,2,4,5-tetrachloro-3-
itrobenzene (Fluka no.: 40384), dimethyl sulfone (Fluka no.:
1867), ethyl 4-(dimethylamino)benzoate (Fluka no.: 42582), ben-
yl benzoate (Fluka no.: 55177), 1,2,4,5-tetramethylbenzene (Fluka
o.: 74658), dimethylmalonic acid (Fluka no.: 89151) and maleic
cid (Fluka no.: 92816). Octamethylcyclotetrasiloxane (Fluka no.:
4811) was puriﬁed and certiﬁed for the experiments (the sub-
tance is not yet available as CRM).
The aminoacids were purchased from Sigma–Aldrich: l-alanine
Fluka no.: 44526), l-arginine monohydrochloride (Fluka no.:
0538), l-asparagine (Fluka no.: 51363), l-aspartic acid (Fluka
o.: 51572), l-cysteine (Fluka no.: 95437), l-cystine (Fluka no.:
9603), l-glutamic acid (Fluka no.: 95436), l-glutamine (Fluka no.:
6523), glycine (Fluka no.: 76524), l-histidine (Fluka no.: 73767), l-
soleucine (Fluka no.: 56241), l-leucine (Fluka no.: 76526), l-lysine
onohydrochloride (Fluka no.: 67448), l-methionine (Fluka no.:
9496), l-phenylalanine (Fluka no.: 40541), l-proline (Fluka no.:
3693), l-serine (Fluka no.: 54763), l-threonine (Fluka no.: 61506),
-tryptophan (Fluka no.: 51145), l-tyrosine (Fluka no.: 91515), l-
aline (Fluka no.: 50848).
Deuterated solvents were purchased from Sigma–Aldrich: deu-
erium oxide D2O (Aldrich no.: 151882, atom % D), sodium
euteroxide, NaOD (Aldrich no.: 372072; 0.40 wt.% in D2O, atom
 D), dimethyl sulfoxide-d6 DMSO-d6 (Aldrich no.: 151874, atom %
), chloroform-d, CDCl3 (Aldrich no.: 151823, atom % D), methanol-
4, CD3OD (Aldrich no.: 151947, atom % D), acetonitril-d3, CD3CN Biomedical Analysis 93 (2014) 102–110 103
(Aldrich no.: 151807, atom % D) and acetic acid-d4 (Aldrich no.:
151785, atom % D).
2.2. High-precision weighing and sample preparation
All weighing steps were performed on a Mettler–Toledo
UMT  5 Ultra microbalance (Mettler–Toledo GmbH, Greifensee,
Switzerland) with a readability of 100 ng, certiﬁed by DAkkS
(Deutsche Akkreditierungsstelle GmbH) and calibrated with OIML
(International Organization of Legal Metrology, Paris) Class E2
weights. The balance is positioned on a three point mounted 700 kg
stone table and a U-electrode is in place to remove potential static
charge. Air buoyancy correction was  considered for the ﬁnal mass
determination [16]. The ratio of the masses was calculated accord-
ing to the number of protons to ensure approximately 1:1 ratios
for the integrals of calibrant and sample. In most cases, between 10
and 50 mg  of substance was weighed out.
For all experiments, seven to ten different samples were
prepared by accurately weighing internal standard and sample
together into an HPLC vial. After adding a suitable deuterated sol-
vent the samples were thoroughly sonicated to completely dissolve
both components, then the solution was transferred to a 5-mm
NMR tube (Schott® NMR  sample tubes, Professional).
2.3. NMR experiments
All NMR  experiments were carried out on a Bruker AVANCE III
600 MHz  spectrometer operating at 600.2 MHz, equipped with a
BBO probe head with z-gradient using a 90◦ pulse width of 14.1 s.
Temperature stability was  controlled by a BVT 3200 unit at 298.2 K.
Determination of the T1 relaxation time was performed using the
inversion recovery experiment which was  performed in automa-
tion mode using 11 different delays that range from 0.01 to 20 s,
the relaxation delay D1 set mostly to 30 s and the number of scans
4 or higher when needed. In total 64,000 data points were acquired.
For evaluation the T1/T2 relaxation module of the software Topspin
2.1 was used with non-linear ﬁt of the peak intensities.
Quantitative NMR  experiments were carried out with seven to
ten different samples for each qNMR series. A number of 16 transi-
ents with 65,536 data points each were collected to ensure a signal
to noise ratio of >300 for the relevant peaks, with a standard sin-
gle pulse experiment without decoupling. All experiments were
carried out under non-spinning conditions with regard to the high
magnetic ﬁeld and to avoid spinning side bands. To receive fully
relaxed NMR  spectra with maximum signal intensity, a 90◦ pulse
was applied. Based on previous T1 inversion recovery experiments
the T1 relaxation delay was checked for each mixture and set
accordingly. In most cases, a relaxation delay of 60 s was chosen
in view of 5 – 7 times T1.
Prior to Fourier transformation a window function was applied
and the spectra were processed with a line broadening of 0.3 Hz,
zero ﬁlling was done once. After carefully manual phasing and auto-
matic baseline correction, the integration of the signals was done
manually. The integration of the calibrant signal and the sample sig-
nal was  always done in the same way  with both signals integrated
with or without 13C satellites. The transmitter frequency offset (O1)
was always set in a way so that neither the calibrant signal nor the
sample signal is affected.
3. Results and discussion
3.1. Traditional purity assignment vs. content determination by
the qNMR approach
Traditionally the purity of organic substances is determined
using chromatographic methods including HPLC or GC, using
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ifferent detectors and supported by additional methods intended
o estimate the amount of further impurities. Chromatography
lways yields the area-percent of all detected signals that add up
o 100%. This procedure ignores the fact that different substances
nd also impurities generate different detector intensities due to
heir different physicochemical properties or at worst may  not be
etected at all. In addition, many impurities may  not be seen by the
etector as they do not elute under the chosen chromatographic
onditions. This means that the determination of purity by chro-
atography can give a very different result from the true purity. A
urther source of error may  be caused by the presence of solvent,
ater and other impurities in the sample. So if a material actually
ontained a total of 10% salt or solvent and impurities, then the true
ontent of the substance is only 90% even though it may  appear to be
99% pure by chromatography. Therefore, chromatographic purity
stimation is normally combined with a variety of additional ana-
ytical techniques. The most commonly used additional analyses
re the determination of water content, residual solvents, loss on
rying, ash content, inorganic trace analysis and residue on igni-
ion. This approach has been widely used for many years in the
ertiﬁcation of organic reference materials and is known as the
ass balance method [17,18] If the mass balance method is applied
roperly it can lead to robust and reliable results. Nevertheless,
he combination of several different analytical techniques requires
n extensive instrumental infrastructure and it is also quite time
onsuming. But even when many different techniques are used to
dentify undetected chromatographic impurities there is no cer-
ainty that all impurities have been detected or quantiﬁed correctly.
oreover, each additional method leads to an increased overall
easurement uncertainty. However the most signiﬁcant drawback
f the traditional approach is the lack of direct traceability to the
I. Traceability to the SI using chromatographic methods and mass
alance can only be achieved if a CRM is available that has the same
hemical structure as the analyte. In the majority of cases, such CRM
re not available.
The technique of qNMR yields both quantitative and qualita-
ive information within one experiment. NMR  spectroscopy is a
on-invasive and non-destructive method and the quantitative
nformation of one analyte can often be obtained even without prior
solation of the compound of interest. Another advantage is that
ample preparation is normally very simple and in combination
ith appropriate metrological weighing infrastructure it unveils
he maximum performance of this technology. Both, sample mate-
ial and the internal standard CRM are weighed directly into the
ame vial and dissolved in a suitable deuterated solvent. As previ-
usly stated the most important advantage of using qNMR for the
ertiﬁcation of organic reference materials is that it is a “relative
rimary” method. This means that the signal intensity is directly
roportional to the number of protons that contribute to the res-
nance. Even more important the signal response or intensity is
ully independent of the chemical structure, i.e. two  signals gener-
ted by the same number of nuclei from two chemically different
ubstances give exactly the same signal intensity. The internal CRM
an be a totally different organic substance, as long as it has protons
nd as long as its chemical purity is well known. Thus thousands of
ifferent organic molecules can be measured and certiﬁed using a
mall set of internal standard CRM.
Since qNMR directly measures the analyte signal and ignores all
mpurities, provided that the sample signal is pure and not over-
apped by impurities, the measurement result is not affected by any
mpurities including otherwise non-detectable impurities such as
ater or inorganic salts.
It must be mentioned that qNMR does have its limitations: the
ost signiﬁcant is that complex mixtures and matrix samples in
ost cases cannot be measured. Compared with many hyphen-
ted techniques, such as GC–MS, the limited sensitivity of qNMR Biomedical Analysis 93 (2014) 102–110
requires at least a few milligrams of material available for certiﬁca-
tion. Hygroscopic and volatile substances can only be certiﬁed by
qNMR with special infrastructure and equipment. The certiﬁcation
of hygroscopic or volatile substances therefore is only possible with
slightly higher measurement uncertainties.
3.2. Traceability concept
The availability of organic CRM with traceability to the SI, certi-
ﬁed purity in mass percent and with low measurement uncertainty,
is very limited. In contrast, the number of organic molecules to
be certiﬁed is extremely high and the chance to ﬁnd the desired
CRM with the necessary prerequisites is low. A large number of
organic substances can now be certiﬁed by qNMR using a set of
newly developed qNMR CRM as internal calibrators. Since those
have uncertainties of less than 0.1% their contribution to the overall
uncertainty budget of the ﬁnal organic CRM is of minor signiﬁcance.
Where applicable, organic substances can also be certiﬁed directly
by using the primary CRM as an internal standard. Fig. 1 shows the
concept of certifying small organic molecules by qNMR, either by
direct measurement against a primary reference or by using one of
the newly developed secondary internal standard CRM for qNMR.
Both approaches guarantee an unbroken traceability chain to the
SI.
3.3. Criteria for the evaluation of a suitable CRM
In general, any organic substance that is a potential candidate
to be used as 1H qNMR internal standard CRM has to fulﬁll certain
prerequisites before being selected as a candidate.
First, there are several basic requirements that must be met:
• availability in very high purity.
• non-hygroscopic and non-volatile.
• low chemical reactivity and toxicity.
• simple signal pattern (few signals only).
• chemical shift of signals covering different areas.
• low ratio of isochronic protons to molecular mass.
• solubility in multiple deuterated solvents.
• reasonable price.
Once a substance fulﬁlls the basic requirements the following
additional speciﬁc requirements for qNMR CRM are important for
the practical application of the molecule and make a chosen candi-
date ﬁt for purpose.
The number of proton signals, that a candidate substance has, is
important. In most cases it is advantageous to have a CRM with pro-
ton signals in different areas of the spectral window. This allows to
quantify the analyte by choosing the most suitable signal, or even
allows to choose more than one signal. Conversely, if the analyte
already has many signals it is beneﬁcial to have a CRM with only one
signal to reduce potential signal overlaps. It is not only the number
of signals, but also the multiplicity pattern, that must be consid-
ered when choosing a candidate CRM. It has been shown that the
multiplicity pattern itself has no inﬂuence on the result [12], but
similar patterns of internal CRM and analyte, as well as simple pat-
terns ease the evaluation. The relevant protons which are chosen
for integration should be non-exchangeable in deuterated solvents,
unless the non-exchangeable proton signals are overlapped (e.g. in
carbohydrates). The relaxation times of all relevant protons of a
candidate should be known, and in particular for high-throughput
analysis labs they should preferably be short, in view of adjusting
the relaxation delay D1 to 5–7 times T1. As relaxation times can par-
tially be estimated from the structure, symmetric molecules tend
to higher relaxation times. Another aspect in the evaluation of a
suitable qNMR CRM is the physical state of the candidate. A solid
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tFig. 1. Traceability concept for the certiﬁcation of organic molecules. I
aterial is preferable for easier handling and weighing, but then its
omogeneity is determined by the minimum weight which means
hat when using less material than stated in the certiﬁcate, the given
easurement uncertainty has to be increased accordingly, which
ay  have a huge impact on the overall measurement uncertainty.
hen increased measurement uncertainty due to lower minimum
eight is undesirable, a liquid candidate may  solve the problem
s it is always homogeneous and thus has no minimum weight.
t is also important to consider the solubility which must be good
n most common polar and non-polar NMR-solvents, so that no
estrictions arise when using large amounts of material. Usually a
andidate CRM should be as stable as possible, but there may be
articular metabolomics application, where it is desirable to have
 sublimable standard (e.g. Durene or a Silane), so that precious
nalytes can be recovered after quantiﬁcation [19].
Based on these criteria only few substances were suitable for
se as 1H qNMR internal CRM and thus following the procedures
escribed above, only a few substances were selected and certi-
ed by 1H qNMR [20] for purity under double accreditation ISO/IEC
7025 [21] and ISO Guide 34 [22].
.4. Toolbox of current 1H qNMR standards
Different analytes require different standards, and due to the
ariety of requirements there is no universal CRM that can serve as
NMR-standard [6], instead there is a need for several ones. Table 1
hows the newly developed internal standard CRM for qNMR quan-
iﬁcation. It details the most important application data, including
hemical shifts, multiplicity, solubilities and relaxation times (T1)
or the corresponding signals, measured in different solvents. These
RM are certiﬁed with relative expanded standard uncertainty val-
es of 0.08–0.17%. The indicated relaxation times are additionally
tated in the certiﬁcates, but have been measured with the sin-
le substance in deuterated solvent. A new determination of T1
fter the addition of internal standard and dissolution of the mix-
ure in the same solvent is always recommended, according toe cases traceability can be realized directly to the primary calibrators.
the procedure described in the experimental section. As a gen-
eral guideline the structure of the molecule can help to estimate
the relaxation time. Aromatic protons with often rather rigid and
often isolated protons will have longer T1 relaxation times. Cal-
cium formate has the longest T1 with 20 s, since it is a salt and
therefore the dipol–dipol interactions will inﬂuence the relaxation
time depending on the concentration [23]. The symmetry of the
molecule also inﬂuences the relaxation time to higher values with
higher symmetry. Some substances offer the use of different pro-
ton signals with different multiplicities for quantiﬁcation. Due to
the different solubilites and chemical shifts, this set of CRM enables
the quantiﬁcation of almost every organic molecule by qNMR.
3.5. Requirements for CRM producers
It is now accepted by all signatories to the International
Laboratory Accreditation Cooperation (ILAC) Mutual Recogni-
tion Arrangement (MRA) that CRM producers should be “double
accredited” to both ISO/IEC 17025 “General requirements for the
competence of testing and calibration laboratories” and ISO Guide
34 “General requirements for the competence of reference material
producers”.
In addition to organization and management requirements
according to ISO 9001, there are several topics that are crucial
for ISO/IEC 17025 compliance including instrument qualiﬁcation,
validation of analytical method, traceability statement, evaluation
of measurement uncertainty, education of personnel and periodic
participation in proﬁciency tests to demonstrate technical capabil-
ity.
ISO Guide 34 outlines the quality system requirements under
which a CRM is produced and deals with aspects regarding produc-
tion planning and control, maintenance of a suitable environment,
starting material selection and processing, assignment of a property
value, their uncertainty and traceability, assessment of homogene-
ity and stability, assurance of adequate packaging and storage and
issuing certiﬁcates or documents.
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Table 1
The Sigma–Aldrich qNMR toolbox comprises a selection of different high-purity CRM that cover the entire spectral range, allowing the quantiﬁcation of almost any organic
molecule by qNMR. The table gives an overview of spectral shifts, multiplicity, solubility and relaxation times in different solvents.
Name Structure ∼ı [ppm] (number of
protons, multiplicity)
Solubility/relaxation time @ 25 ◦C
D2O CDCl3 DMSO-d6 CD3OD CD3CN
Calcium formate 7.6 (2H s) 20 s – – – –
Benzoic acid 8.3–7.3 (5 H m)  – 4.4 s 3.2 s 3.3 s 5.8 s
Duroquinone 1.8–2.2 (12 H s) – 3.2 s 2.7 s 4.2 s 4.6 s
Dimethyl terephthalate 8.1 (4H s)
3.9 (6H s)
– 4.0 s
2.1 s
3.1 s
1.4 s
4.7 s
2.7 s
5.7 s
3.1 s
Potassium phthalate
monobasic
8.3–7.0 (4H m)  2.4 s– – 3.4 s –
3,5,-Dinitrobenzoic acid 8.8–9.2 (3H m) – – 6.7 s 6.3 s 8.0 s
1,2,4,5-Tetrachloro-3-
nitro-benzene
7.6–8.7 (1H s) – 7.6 s 11.9 s 8.9 s 10.0 s
Dimethyl sulfone 3.0 (6H s) 6.5 s4.7 s 3.8 s 2.9 s 5.9 s
Ethyl  4-(dimethylamino)
benzoate
∼1.3 (3H t)
∼3.0 (6H s)
∼4.3 (4H q)
∼6.7 (2H d)
∼7.8 (2H d)
– 2.6 s
2.8 s
2.3 s
2.3 s
4.0 s
2.1 s
1.5 s
1.8 s
1.4 s
2.8 s
2.9 s
2.8 s
3.1 s
2.6 s
4.1 s
3.6 s
3.4 s
4.0 s
3.4 s
5.5 s
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Table  1 (Continued)
Name Structure ∼ı [ppm] (number of
protons, multiplicity)
Solubility/relaxation time @ 25 ◦C
D2O CDCl3 DMSO-d6 CD3OD CD3CN
Benzyl benzoate ∼5.4 (CH2, s) – 2.5 s 1.4 s 2.9 s 3.5 s
1,2,4,5-
Tetramethylbenzene
6.9 (2 H s) – 5.4 s 4.8 s 6.1 s 7.1 s
2.2  (12H s) – 3.4 s 2.6 s 4.3 s 4.5 s
Dimethylmalonic acid 1.3–1.4 (6H s) 975 ms – 604 ms  938 ms  –
Maleic acid 6.3 (2H s) 6.3 s – 3.1 s 4.2 s 6.1 s
Octamethylcyclotetrasiloxane 0.08 (24H s) – 2.6 s – 4.4 s 3.5 s
s
O
i
d
m
a
t
h
r
s
t
i
f
t
3
d
i
n
s
m
a
ﬁ
The certiﬁcation procedure for neat organic materials at
Sigma–Aldrich is shown in Fig. 2 and includes a series of different
consecutive steps including processing of the candidate material,
Candidate Reference Material
Reference for Traceability
(i.e. SRM from NIST) Pre-tests
Homogeneity Testing
Content Determination by  qNMR
High Precision Weighing
Certified Reference Material
Long-term Stability  Test
Accelerated Stability Test
Addi tional  Cha ract erisatio n
Certified Value & Uncertainty
Review and CertificationFurthermore ISO Guide 34 clearly states the requirements for
tability testing and also refers to ISO Guide 35 for further details.
ne important aspect regarding stability studies in ISO Guide 35
s the monitoring of the stability. The evaluation of measurement
ata as described in ISO Guide 35 covers only apparently stable
aterials. In case of detectable degradation, both the degradation
nd its uncertainty shall be included in the stability assessment. In
heir work, Bremser et al. [24] gave an alternative approach for data
andling and a model based estimation of expiry date for instable
eference materials.
In ISO Guide 35 [25] a distinction is made between “short-term
tability” that can be described as the stability under speciﬁed
ransport conditions and “long-term stability” which is the stabil-
ty under particular storage conditions. The stability data are used
or the deﬁnition of the shelf life and the recommended storage
emperature of a CRM as described in Section 3.6.4.
.6. Certiﬁcation procedure using HP-qNMR at Sigma–Aldrich
The aim was to establish a feasible and valid process for the
evelopment of qNMR CRM in an industrial environment that is
n accordance with all relevant ISO guides. Key to the process is a
ew certiﬁcation concept based on the measurement of different
amples from within the entire bulk-material before dispensing the
aterial into the ﬁnal packaging container. The classical concept,
ccording to ISO Guide 35, describes the measurement of already
lled material and associated between-bottle measurements. Thenew concept of “bulk-certiﬁcation” prior to the ﬁlling process gen-
erates further speciﬁcities that will be discussed in the following
chapters.according to 
ISO/IEC 17025  an d ISO  Guid e 34
(HPLC, LC-MS, GC, CHN, mp,
titration, trace impurities, others)
Fig. 2. Workﬂow of the entire certiﬁcation procedure at Sigma–Aldrich under
ISO/IEC 17025 and ISO Guide 34.
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ampling, pre-tests, metrological weighing, NMR-spectroscopy,
omogeneity study, accelerated stability studies (short-term),
ong-term stability studies, additional analyses, evaluation of mea-
urement uncertainty, creating certiﬁcates and certain logistic
undamentals.
.6.1. Sampling
The sampling procedure is one of the ﬁrst steps in a certiﬁcation
rocess. It must be precisely deﬁned with respect to the number
nd size of samples that are necessary for qNMR-, homogeneity-
nd stability-measurements. According to the concept of bulk-
ertiﬁcation, this step comprises a representative sampling of the
ntire bulk starting material taken from different positions. A total
f seven to ten samples are taken for the purity determination, addi-
ionally three samples are taken for short-term stability studies,
wo samples are taken for long-term stability studies and one sam-
le is taken for further analyses. The size of each sample is around
00 mg,  and 10–20 mg  of a sample are required for the correspond-
ng qNMR-measurements.
.6.2. Pre-tests
A  series of pre-tests must be carried out prior to any qNMR quan-
iﬁcation experiment. First, the chemical compatibility between
ample and internal standard CRM is checked by acquiring a pro-
on NMR  spectrum of the mixture right after preparation and again
fter 24 h. It is important that the relevant signals for quantiﬁca-
ion do not overlap each other and there should not be interference
y potential impurities. Several tests are applied to ensure that
o impurity underlies the peaks of interest. This is done using
hromatographic methods in combination with 2D H/H COSY NMR
xperiments where impurities of 0.05% signal intensity portion can
e detected. Since the relaxation time can vary depending on the
ixture and the solvent, the T1 relaxation time was evaluated using
he inversion recovery method.
Checking the hygroscopy or volatility of the chemical substances
s also very important. Only non-volatile and non-hygroscopic
andidate CRM were chosen to obtain best weighing results. A sub-
tance is deﬁned to be suitable when no change in weighing value
f greater than 0.02 mg  was  obtained over a time period of 10 min.
In addition to the determination of the certiﬁed value, which
as already been published [12], further factors that could affect
he CRM content need to be identiﬁed und evaluated in detail.
hese are in particular the homogeneity and stability of the
aterial.
.6.3. Homogeneity testing
Even when a material is expected to be homogeneous, as in the
ase of solutions [26] or highly puriﬁed substances, an assessment
f the homogeneity is required. There is an experimental limit to
he detection of inhomogeneity and the measurement method with
est repeatability should be used. Drift during the measurements,
oo small sample amounts and an insufﬁcient repeatability of the
ethod can lead to an overestimation of the inhomogeneity of the
aterial.
The homogeneity of the bulk-material is also tested by qNMR
easurements using seven to ten samples that are taken from three
ifferent positions (top, middle, bottom) within the entire bulk-
aterial. The recommended minimal sample amount, given in the
ertiﬁcate, is used for all homogeneity measurements. One-way
NOVA (analysis of variance) results are included in the uncer-
ainty evaluation. In cases where ANOVA shows, for experimental
easons, a negative value, the relative standard deviation of means
f the different samples (top, middle, bottom) is included as max-
mum uncertainty contribution from inhomogeneity (uhom). Since
omogeneity is not additionally tested in ﬁlled units, as described Biomedical Analysis 93 (2014) 102–110
in ISO Guide 35, no contribution from between-bottle homogeneity
is added.
3.6.4. Stability study scheme
The stability study should be designed in a way that it yields suf-
ﬁcient data for answering questions about the long-term stability
of the CRM at the deﬁned storage temperature, about the maximum
impact on the CRM during transport conditions and provide data
for an appropriate estimation of the shelf-life.
In contrast to the recommendations in ISO Guide 35, where
short-term stability tests are typically carried out only for a few
weeks, an accelerated stability test (AST) designed to give results
over a prolonged period of time is used. The advantages of such a
design are described in detail by Ellison et al. [27] and he shows
that the accelerated studies detect instabilities better than the
long-term study at storage temperature. It can also give earlier
predictions about the stability model (stable, linear, exponential
or autocatalytic degradation).
Stability study samples are analyzed at different points in time,
meaning that several months can lie between two measurement
values, therefore the reproducibility of the measurement method is
of primary importance. Because qNMR demonstrates an excellent
reproducibility and a low measurement uncertainty it is chosen
as an appropriate analytical method for the determination of the
content during stability studies.
3.6.4.1. Accelerated stability test (AST). AST is performed at elevated
temperature, usually 20 ◦C above the indicated storage tempera-
ture. Duplicate tests are performed at deﬁned time points, one,
three, nine and in some cases eighteen months. If the CRM turns
out not to be stable at elevated temperature this may  lead to a
reduction of the general storage temperature or particular storage
information in the certiﬁcate and to a new start of the AST.
3.6.4.2. Long-term stability test (LTS). The long-term stability stud-
ies are performed in parallel at the indicated storage temperature
and for a longer time-period, which typically covers the entire
shelf-life of a CRM. Typical time-points are 24, 36 and 48 months.
The earlier time-points (one, three and nine months) are only mea-
sured if the corresponding AST indicates a signiﬁcant instability.
Certiﬁcation is only accomplished when AST and LTS data
indicate a sufﬁcient CRM stability at the recommended storage
condition. Under these assumptions the shelf-life can be estimated
using AST data and the Arrhenius equation, where a reduction in
storage temperature by 10 ◦C results in a prolongation of the shelf-
life of two to four times. For a stable CRM, all recorded values should
lie within the measurement uncertainty of the certiﬁed value and
therefore no correction for possible instability is needed. Never-
theless AST and LTS data are used for the estimation of uncertainty
contribution coming from storage, ustab, which is included into the
overall measurement uncertainty. Data from both tests of a previ-
ously tested CRM lot are additionally used to decide about a possible
prolongation of the shelf-life of a second CRM lot.
The newly developed CRM for qNMR quantiﬁcation (Table 1)
show, besides other key features, excellent stabilities during AST
and LTS. For this reason the set of aminoacids illustrate in a much
better way  the importance of a prolonged AST.
Fig. 3a and b show the behavior of 21 aminoacids under AST
and LTS conditions. The AST was  conducted at 45 ◦C and shows
the purity of each substance determined by qNMR at various time-
points (t = 0/1/3/9 months). All purity data for t = 0 were normalized
to 1.0, and the other data calculated accordingly. Arginine is the
only CRM that turned out to be unstable after 3 months at 45 ◦C.
In this case, the storage temperature of arginine was  reduced to
4 ◦C, and a new AST was  started at room temperature. In contrast,
M. Weber et al. / Journal of Pharmaceutical and Biomedical Analysis 93 (2014) 102–110 109
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[ig. 3. Accelerated stability test (Fig. 3a) and long-term stability test (Fig. 3b) for diff
easurement uncertainties (k = 2).
ll substances were stable in the long-term stability test at room-
emperature (approx. 23 ◦C) over a time-period of 3 years.
Using a classical short-term stability test, which typically would
nly cover the time during transport or shipping, may  have been
oo short to detect the instability of arginine. These data show the
mportance of a longer testing period at elevated temperature con-
itions. With regard to different potential degradation kinetics, a
eriod of nine months was chosen as the minimum time interval for
ST and 18 months used for particular cases, especially for prolon-
ation of shelf-life. In combination with the LTS data, this enables
 sound determination of shelf-life.
.7. Uncertainty evaluation
The certiﬁed value wCRM can be described as
CRM = wcert + whom + wstab
wcert represents the value obtained from the characterization of
he bulk-material, whom denotes an uncertainty contribution due to
he possible inhomogeneity (for details see Section 3.6.3) and wstab
s an uncertainty contribution due to stability testing (for details see
ection 3.6.4). The homogeneity and stability studies are designed
n such a way that the values of these terms are zero, but their
ncertainties are not.
The combined standard uncertainty of the certiﬁed value (uCRM)
s calculated according to EURACHEM/CITAG Guide [28]:
CRM =
√
u2cert + u2hom + u2stab
A detailed discussion about the measurement uncertainty of HP-
NMR (ucert) was given previously [12].
. Conclusions
As an accredited lab, the overall concept for the certiﬁcation
nd production of reference materials has to be a robust pro-
ess that is in accordance with ISO/IEC 17025 and ISO Guide
4. Details of this elaborated multi-step procedure are shown
n this work. Since qNMR generates accurate and traceable val-
es in combination with low measurement uncertainties, it is
n optimal technique for the content determination of organic
olecules. QNMR is capable of detecting even small differences
n content, and therefore best suited for conducting stability stud-
es.
Full compliance with ISO Guides 34 and 35 is given, which
equires the implementation of homogeneity and stability tests
nder different conditions. The good reproducibility of the
[
[aminoacids. The certiﬁed values are normalized to 1.0. The bars show the expanded
technique, on a month-to-month basis, allows an exact content
determination particularly for LTS studies and is therefore able to
show even minor differences that may  arise from potential degra-
dation processes. AST data not only serve to guarantee product
safety during transport, but in combination with LTS data also are
used to calculate the prospective shelf-life of a CRM. Therefore,
prolonged AST studies show clear advantages over long-term
stability tests under storage conditions, as potential instabilities
can be detected earlier.
A set of certiﬁed reference materials, ideal for the use as inter-
nal references for quantitative NMR, is shown, including additional
application data, such as spectral shifts, multiplicity, solubility and
relaxation times in the most common solvents.
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